Today, we're diving into a hot topic in the world of health and wellness: semaglutide. You might have heard about this ...

A massive real-world study comparing tirzepatide and semaglutide reveals both drugs deliver strong, early cardiovascular ...

Both semaglutide and tirzepatide are associated with improvements in quality of life for adults with obesity, though ...

WASHINGTON -- Semaglutide (Wegovy) improved liver inflammation and fibrosis in patients with metabolic dysfunction-associated ...

This article was reviewed by Darragh O’Carroll, MD. Semaglutide Side Effects: What to Know Key takeaways: Common semaglutide ...

Oral semaglutide 25 mg was associated with improved glycemic parameters and cardiovascular risk across weight loss categories ...

Semaglutide reduced liver fibrosis and resolved MASH in the ESSENCE trial, offering dual hepatic and metabolic benefits. Read ...

At the American Association for the Study of Liver Diseases (AASLD) annual meeting, a session highlighted new guidance on ...

A Novo Nordisk challenge has driven Regen Doctors to voluntarily discontinue compounded semaglutide product claims, adding to ...

In a randomized trial of adults with obesity or overweight, Vanda Pharmaceuticals’ investigational NK-1 receptor antagonist ...

Semaglutide therapy was associated with higher likelihood of passing low-risk cardiovascular thresholds among patients with ...